AdaptHealth Corp.
Close on Oct 19, 2026
- Market cap
- $800.39M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 3, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 4, 2026 | Before market open | $740.30M | – | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 5, 2026 | Before market open | $819.80M | $-0.12 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 24, 2026 | Before market open | $846.30M | $-0.76 | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 4, 2025 | Before market open | $820.30M | $0.16 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 5, 2025 | Before market open | $800.40M | $0.10 | $0.10 |
| Q1 FY2025 Ended Mar 31, 2025 | May 6, 2025 | Before market open | $777.90M | – | – |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 25, 2025 | Before market open | $856.60M | $0.34 | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 5, 2024 | Before market open | $805.90M | $0.15 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 6, 2024 | Before market open | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 7, 2024 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 27, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on Aug 4, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDAnon-GAAP | fiscal year 2026 | $490.00M to $520.00M | Lowered |
| Free cash flownon-GAAP | fiscal year 2026 | $80.00M to $120.00M | Lowered |
| Net revenue | fiscal year 2026 | $2.85B to $2.89B | Lowered |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements AdaptHealth filed with the SEC
AdaptHealth Appoints Harriss Currie as Chief
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2026 RESULTS
Results of operations · EX-99.1 to Form 8-K
ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2026 RESULTS
Results of operations · Executive or director change · EX-99.1 to Form 8-K
AdaptHealth Corp. Announces Refinancing of Senior Secured Credit Facility Resulting in Extended Maturity, Reduced Cost of Debt, and Enhanced Financial Flexibility
Material agreement · Agreement terminated · New financial obligation · Regulation FD disclosure · EX-99.1 to Form 8-K
ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
Results of operations · EX-99.1 to Form 8-K
ADAPTHEALTH CORP. ANNOUNCES THIRD QUARTER 2025 RESULTS
Results of operations · EX-99.1 to Form 8-K
ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2025 RESULTS
Results of operations · EX-99.1 to Form 8-K
CORP. PARTNERS WITH A MAJOR NATIONAL HEALTHCARE SYSTEM TO BECOME THE EXCLUSIVE PROVIDER OF HOME MEDICAL EQUIPMENT
Regulation FD disclosure · EX-99.1 to Form 8-K
ADAPTHEALTH CORP. CLOSES TRANSACTION TO DISPOSE
Regulation FD disclosure · EX-99.1 to Form 8-K
ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2025 RESULTS
Results of operations · EX-99.1 to Form 8-K
ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2024 RESULTS
Results of operations · EX-99.1 to Form 8-K
ADAPTHEALTH CORP. ANNOUNCES THIRD QUARTER 2024 RESULTS
Results of operations · EX-99.1 to Form 8-K
AdaptHealth Appoints Diana Nole to Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
TO THE HOLDERS OF ADAPTHEALTH CORP.
Regulation FD disclosure · EX-99.1 to Form 8-K
of Senior Secured Credit Facility Resulting in Extended Maturity and Reduced Cost of Debt
Material agreement · New financial obligation · Regulation FD disclosure · EX-99.1 to Form 8-K
WIRE)-- AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) , a national leader in providing
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2024 RESULTS
Results of operations · EX-99.1 to Form 8-K
ADAPTHEALTH CORP. ANNOUNCES CHANGES TO BOARD
Executive or director change · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2024 RESULTS
Results of operations · EX-99.1 to Form 8-K
ADAPTHEALTH APPOINTS SUZANNE FOSTER AS CHIEF
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 RESULTS
Results of operations · EX-99.1 to Form 8-K
ADAPTHEALTH CORP. ANNOUNCES THIRD QUARTER 2023 RESULTS
Results of operations · EX-99.1 to Form 8-K
ADAPTHEALTH CORP. ANNOUNCES SECOND QUARTER 2023 RESULTS
Results of operations · EX-99.1 to Form 8-K
AdaptHealth Appoints Crispin Teufel as New Chief Executive Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Stephen Griggs Will Step Down as CEO at the End of Second Quarter
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2023 RESULTS
Results of operations · EX-99.1 to Form 8-K
ADAPTHEALTH CORP. ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2022 RESULTS
Results of operations · EX-99.1 to Form 8-K
PROVIDES Full-year 2023 Guidance AND
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
CORP. Announces THIRD Quarter 2022 RESULTS
Results of operations · EX-99.1 to Form 8-K
REPORTS SECOND Quarter 2022 Results
Results of operations · EX-99.1 to Form 8-K
REPORTS FIRST Quarter 2022 Results, UPDATES 2022 guidance,
Results of operations · EX-99.1 to Form 8-K
REPORTS Fourth Quarter and Full-Year 2021 Results
Results of operations · EX-99.1 to Form 8-K
ADAPTHEALTH ANNOUNCES THIRD QUARTER 2021
Results of operations · EX-99.1 to Form 8-K